Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment with Buprenorphine: A Pilot Study
Authors:
- 4 March 2015
- journal article
- other
- Published by SAGE Publications in Substance Abuse
- Vol. 36 (2) , 166-169
Abstract
Background: Shared medical appointments (SMAs) are designed to improve patient satisfaction and increase access to treatment. In a typical SMA, 6–12 patients with similar diagnoses attend a group appointment with their health care providers, often lasting 60–120 minutes. All components of an individual visit are completed, and additional time is spent providing education and facilitating peer support. The aim of this study was to report on patient and program outcomes after implementation of SMA-based office-based opioid treatment with buprenorphine. Methods: The study was conducted at a hospital-based outpatient psychiatric clinic that previously did not offer any office-based opioid treatment with buprenorphine. Demographic and clinical data (treatment retention, depression, anxiety, craving scores, and urine toxicology results) were extracted from the medical records. Patients were recruited to complete a survey assessing their experience. Results: Ninety-three patients enrolled in the program, and 52.7% remained in treatment at 6 months. The proportion of aberrant opioid urine results, depression, anxiety, and craving decreased significantly from baseline to 6 months. Twenty-two patients completed the survey, who generally agreed that the SMA format allowed for more time with physicians, more support from peers, better coordination of care, and more predictable times for visits. Conclusions: Implementation of an SMA-based buprenorphine program was feasible, with treatment outcomes comparable to traditional models of care. More research is needed to explore the impact of SMA on buprenorphine treatment.Keywords
This publication has 12 references indexed in Scilit:
- Emerging adult age status predicts poor buprenorphine treatment retentionJournal of Substance Abuse Treatment, 2014
- Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine–naloxone and standard medical management?Drug and Alcohol Dependence, 2014
- Primary care patient characteristics associated with completion of 6-month buprenorphine treatmentAddictive Behaviors, 2013
- Medical Clinics Versus Usual Care for Patients With Both Diabetes and HypertensionAnnals of Internal Medicine, 2010
- Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized studyInternational Journal of Neuropsychopharmacology, 2008
- Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid DependenceNew England Journal of Medicine, 2006
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Shared medical appointments: increasing patient access without increasing physician hours.Cleveland Clinic Journal of Medicine, 2004
- The Relationship Between Cocaine Craving, Psychosocial Treatment, and Subsequent Cocaine UseAmerican Journal of Psychiatry, 2003
- The PHQ-9Journal of General Internal Medicine, 2001